HomeHLTRF • OTCMKTS
add
HLS Therapeutics Inc
Previous close
$2.59
Year range
$2.45 - $4.55
Market cap
104.49M CAD
Avg Volume
23.00
P/E ratio
-
Dividend yield
-
Primary exchange
TSE
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 12.47M | -15.48% |
Operating expense | 12.90M | -16.34% |
Net income | -6.11M | -5.42% |
Net profit margin | -48.95 | -24.71% |
Earnings per share | -0.19 | -9.57% |
EBITDA | 2.45M | -52.26% |
Effective tax rate | 0.47% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 19.44M | -8.35% |
Total assets | 197.75M | -15.55% |
Total liabilities | 108.68M | -5.71% |
Total equity | 89.07M | — |
Shares outstanding | 31.81M | — |
Price to book | 0.93 | — |
Return on assets | -4.26% | — |
Return on capital | -4.82% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -6.11M | -5.42% |
Cash from operations | 778.00K | -80.65% |
Cash from investing | -2.00K | — |
Cash from financing | -3.03M | 13.66% |
Net change in cash | -2.51M | -611.00% |
Free cash flow | 2.71M | -44.63% |
About
Founded
2014
Website
Employees
91